These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 10657112

  • 1. Investigation of gene therapy begins.
    Fox JL.
    Nat Biotechnol; 2000 Feb; 18(2):143-4. PubMed ID: 10657112
    [No Abstract] [Full Text] [Related]

  • 2. Restoring public trust in gene therapy.
    Kennedy EM.
    J Biolaw Bus; 2001 Feb; 4(3):3-4. PubMed ID: 12962103
    [No Abstract] [Full Text] [Related]

  • 3. More flexibility on reporting to federal agencies about injuries to research subjects.
    Maloney DM.
    Hum Res Rep; 2002 Jan; 17(1):1-2. PubMed ID: 16270435
    [No Abstract] [Full Text] [Related]

  • 4. Light, fast, and flexible: a new approach to regulation of human gene therapy.
    Cregan JA.
    McGeorge Law Rev; 2000 Jan; 32(1):261-87. PubMed ID: 15709266
    [No Abstract] [Full Text] [Related]

  • 5. Safety panel backs principle of gene-therapy trials.
    Check E.
    Nature; 2002 Dec 12; 420(6916):595. PubMed ID: 12478252
    [No Abstract] [Full Text] [Related]

  • 6. Researchers and regulators reflect on first gene therapy death.
    Hollon T.
    Nat Med; 2000 Jan 12; 6(1):6. PubMed ID: 10613797
    [No Abstract] [Full Text] [Related]

  • 7. Inquiry into gene therapy widens.
    Grisham J.
    Nat Biotechnol; 2000 Mar 12; 18(3):254-5. PubMed ID: 10700127
    [No Abstract] [Full Text] [Related]

  • 8. US plans to protect clinical research participants.
    Fox JL.
    Nat Biotechnol; 2000 Jul 12; 18(7):709. PubMed ID: 10888829
    [No Abstract] [Full Text] [Related]

  • 9. NIH under fire over gene-therapy trials..
    Wadman M.
    Nature; 2000 Jan 20; 403(6767):237. PubMed ID: 10659820
    [No Abstract] [Full Text] [Related]

  • 10. Tighter watch urged on adenoviral vectors...with proposal to report all 'adverse events'.
    Smaglik P.
    Nature; 1999 Dec 16; 402(6763):707. PubMed ID: 10617181
    [No Abstract] [Full Text] [Related]

  • 11. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
    Couzin J, Kaiser J.
    Science; 2005 Feb 18; 307(5712):1028. PubMed ID: 15718439
    [No Abstract] [Full Text] [Related]

  • 12. Gene therapy investigations proliferate.
    Hollon T.
    Nat Med; 2000 Mar 18; 6(3):235. PubMed ID: 10700200
    [No Abstract] [Full Text] [Related]

  • 13. Cancer fears cast doubts on future of gene therapy.
    Check E.
    Nature; 2003 Feb 13; 421(6924):678. PubMed ID: 12610583
    [No Abstract] [Full Text] [Related]

  • 14. NIH panel may increase gene-trial scrutiny..
    Smaglik P.
    Nature; 2000 Jun 15; 405(6788):724. PubMed ID: 10866166
    [No Abstract] [Full Text] [Related]

  • 15. Policy statement of the American Society of Gene Therapy on reporting of patient adverse events in gene therapy trials.
    Woo SL.
    Mol Ther; 2000 Jan 15; 1(1):7-8. PubMed ID: 10933905
    [No Abstract] [Full Text] [Related]

  • 16. Making clinical trials safer for human subjects.
    Baram M.
    Am J Law Med; 2001 Jan 15; 27(2-3):253-82. PubMed ID: 11467112
    [No Abstract] [Full Text] [Related]

  • 17. Gene therapy for rare diseases.
    Nat Genet; 1999 Aug 15; 22(4):313-4. PubMed ID: 10431225
    [No Abstract] [Full Text] [Related]

  • 18. A tumultuous year for gene therapy.
    Verma IM.
    Mol Ther; 2000 Nov 15; 2(5):415-6. PubMed ID: 11082313
    [No Abstract] [Full Text] [Related]

  • 19. US authorities uphold suspension of SCID gene therapy.
    Fox JL.
    Nat Biotechnol; 2003 Mar 15; 21(3):217. PubMed ID: 12610555
    [No Abstract] [Full Text] [Related]

  • 20. NIH tightens up monitoring of gene-therapy mishaps.
    Smaglik P.
    Nature; 2000 Mar 02; 404(6773):5. PubMed ID: 10716412
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.